Mullerian Inhibiting Substance Enhances Subclinical Doses of Chemotherapeutic Agents to Inhibit Huma...
Mullerian Inhibiting Substance Enhances Subclinical Doses of Chemotherapeutic Agents to Inhibit Human and Mouse Ovarian Cancer
About this item
Full title
Author / Creator
Publisher
United States: National Academy of Sciences
Journal title
Language
English
Formats
Publication information
Publisher
United States: National Academy of Sciences
Subjects
More information
Scope and Contents
Contents
Mullerian Inhibiting Substance (MIS), a biological modifier that causes regression of Mullerian ducts in male embryos, is effective as a single agent in vitro and in vivo against human and mouse ovarian cancer cell lines expressing MIS type II receptor; however, little is known about how recombinant human MIS (rhMIS), now being scaled for preclinic...
Alternative Titles
Full title
Mullerian Inhibiting Substance Enhances Subclinical Doses of Chemotherapeutic Agents to Inhibit Human and Mouse Ovarian Cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1859945
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1859945
Other Identifiers
ISSN
0027-8424
E-ISSN
1091-6490
DOI
10.1073/pnas.0607959103
